Can reduced thyroid hormone signaling cause low luteal progesterone?

The relationship between thyroid health and reproductive function is well-established, with emerging research highlighting how reduced thyroid signaling directly impacts the ovaries and the production of progesterone.

Clinical and Mechanistic Evidence

Thyroid hormones (T3 and T4) are essential regulators of the hypothalamic-pituitary-ovarian (HPO) axis. Reduced signaling, whether through clinical hypothyroidism or subclinical dysfunction, impairs the synergy between thyroid-stimulating hormone (TSH), follicle-stimulating hormone (FSH), and luteinizing hormone (LH).

• Direct Ovarian Signaling: Thyroid hormone receptors (TRα and TRβ) are located directly on human granulosa cells, oocytes, and the corpus luteum. Triiodothyronine (T3) acts as a co-gonadotropin, enhancing FSH-induced aromatase activity and LH-stimulated progesterone production.
• Steroidogenic Support: Mechanistically, T3 binds to receptors in granulosa cells to upregulate the expression of the steroidogenic acute regulatory protein (StAR) and 3β-hydroxysteroid dehydrogenase (3β-HSD). These enzymes are the "rate-limiting" steps in converting cholesterol into progesterone. When thyroid signaling is reduced, the expression of these enzymes drops, leading to significantly diminished progesterone output.
• Protection of Ovarian Follicles: T3 supports follicular maturation by activating pathways (such as GRP78 via the coactivator PGC-1α) that protect granulosa cells from oxidative stress and ferroptosis. Reduced signaling can therefore lead to impaired follicular development and suboptimal ovulation.

Impact on Progesterone and the Luteal Phase

Disrupted ovulation is a primary driver of corpus luteum (CL) dysfunction, often referred to as luteal phase deficiency (LPD).

• Secondary Hyperprolactinemia: Hypothyroidism often leads to elevated levels of Thyrotropin-Releasing Hormone (TRH), which stimulates the release of prolactin. Excess prolactin inhibits the pulsatile secretion of GnRH and LH, which are necessary to stimulate the corpus luteum to produce progesterone.
• Corpus Luteum Capacity: Even if ovulation occurs, reduced thyroid signaling limits the secretory capacity of the CL. Studies show that subclinical hypothyroidism (often defined as TSH > 2.5–4.5 mIU/L) is associated with lower luteal phase progesterone levels and a shortened luteal phase. Clinical data suggests that thyroid supplementation can restore ovulatory regularity and normalize progesterone levels.

Bottom line

Reduced thyroid hormone signaling disrupts the delicate endocrine cross-talk required for healthy ovulation. By failing to upregulate key steroidogenic enzymes and protect developing follicles, thyroid dysfunction leads to a compromised corpus luteum and insufficient luteal progesterone production.